Autor: |
Katherine Rankin, Priyanka Hastak, Alexander Wong, Sarah C. Sasson, Brendan Beaton, Avani Yeola, Andrew Warden, Stuart Turville, Anthony D. Kelleher, Fabienne Brilot, Judith Trotman |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
eJHaem, Vol 4, Iss 3, Pp 728-732 (2023) |
Druh dokumentu: |
article |
ISSN: |
2688-6146 |
DOI: |
10.1002/jha2.724 |
Popis: |
Abstract Patients with Waldenström macroglobulinaemia (WM) are at increased risk of severe COVID‐19 infection and have poor immune responses to COVID‐19 vaccination. This study assessed whether a closely monitored pause in Bruton's Tyrosine Kinase inhibitor (BTKi) therapy might result in an improved humoral response to a 3rd COVID‐19 vaccine dose. Improved response was observed in WM patients who paused their BTKi, compared to a group who did not pause their BTKi. However, the response was attenuated after BTKi recommencement. This data contributes to our understanding of vaccination strategies in this patient group and may help inform consensus approaches in the future. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|